During the past decade, Next Level Urgent Care conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 6 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 6 clinical trials were completed. i.e. 46.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Next Level Urgent Care" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Pulmotect, Inc." with 2 trials sponsored, "Altimmune, Inc." with 1 trials sponsored and "Appili Therapeutics Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Next Level Urgent Care" #1 collaborator was "United States Department of Defense" with 2 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Shanghai Junshi Bioscience Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Next Level Urgent Care" are "COVID-19" (7 trials), "Alzheimer Disease" (1 trials), "Coronavirus Infection" (1 trials), "Covid19" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Next Level Urgent Care" in a lesser frequency.

Most popular intervention types in "Next Level Urgent Care" are "Drug" (12 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "PF-07321332" (2 trials), "PUL-042 Inhalation Solution" (2 trials), "Ritonavir" (2 trials) and "Apixaban 2.5 MG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Next Level Urgent Care" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Next Level Urgent Care". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Next Level Urgent Care, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Next Level Urgent Care, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".